Bowling Vaccine & Pharmaceutical Inc is categorized under Biological Research in San Francisco, CA and active since 2002.
Bowling Vaccine & Pharmaceutical Inc was established in 2002, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Steven J Dunn at the company’s single location by writing to 1631 45th Avenue, San Francisco, California CA 94122 or by phoning (415) 731-8649. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bowling Vaccine & Pharmaceutical Inc |
| Contact Person: | Steven J Dunn |
| Address: | 1631 45th Avenue, San Francisco, California 94122 |
| Phone Number: | (415) 731-8649 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Bowling Vaccine & Pharmaceutical Inc was started in 2002 to provide professional Biological Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Steven J Dunn for inquiries that concern Bowling Vaccine & Pharmaceutical Inc by calling the company number (415) 731-8649, as your correspondence is most welcome. Additionally, the physical location of the single location of Bowling Vaccine & Pharmaceutical Inc can be found at the coordinates 37.756127,-122.504738 as well as the street address 1631 45th Avenue in San Francisco, California 94122.
For its online presence, you may visit Bowling Vaccine & Pharmaceutical Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.